24 January 2017: Promotion of unlicensed use of Botulinum Toxin
Published 24 February 2017
An anonymous healthcare professional complained about the article 바카라 사이트Treating obesity with Botulinum Toxin바카라 사이트 published in the December 2016 edition of the Aesthetics Journal. The complainant alleged that the article was a disguised promotion for an off label indication for Galderma바카라 사이트s Botulinum Toxin product.
The MHRA did not uphold the complaint. Galderma stated that they had no involvement in the writing, publication or distribution of the article. The authors of the article also confirmed that the article expressed their opinion and was commissioned and written as an independent scientific review.